Section 661.35  Designation of Consultants

a)         The Chief of the Division of Health Assessment and Screening, with the advice of the Director of the University of Illinois at Chicago, Division of Specialized Care for Children, and the Advisory Committee, shall designate qualified professionals to serve as Consultants to specified subprograms within the Newborn Screening Program.

b)         Equivalency in all qualifications specified in this Section shall be determined by the Chief of the Division of Health Assessment and Screening, with the advice of the Director of the University of Illinois at Chicago, Division of Specialized Care for Children, and the Chairman of the Advisory Committee.

c)         The minimum qualifications required for designation as a consultant are a license to practice medicine in all its branches in Illinois, or licensure in the state of practice, certification by the American Board of Pediatrics or equivalent board from another country.  In addition, to be designated to serve specified subprograms, Consultants shall also have the following qualifications:

1)         Phenylketonuria (PKU) and all other disorders of amino acid and organic acid metabolism:  certification by the American Board of Medical Genetics in Clinical Biochemical Genetics with at least one year experience post-training in diagnosis and treatment of amino acid and organic acid disorders; or certification by the American Board of Medical Genetics in Clinical Genetics, with extensive experience in the diagnosis and treatment of amino acid and organic acid disorders. The consultant shall have the capacity to provide a multidisciplinary approach to care, including the availability on-site of specially trained metabolic dieticians and a biochemical genetics laboratory; for citrullinemia and argininosuccinic aciduria, should have on-site availability of required medical therapies, such as hemodialysis, that are necessary for the treatment of patients with these disorders.

2)         Primary Hypothyroidism:  training in Pediatric Endocrinology with membership in the Lawson Wilkins Pediatric Endocrinology Society or certification of special competence in Pediatric Endocrinology by the American Board of Pediatrics with at least one year experience post-training in diagnosis and treatment of endocrine disorders.

3)         Galactosemia:  certification by the American Board of Medical Genetics in Clinical Biochemical Genetics with at least one year of experience post-training in diagnosis and treatment of children with galactosemia and inborn errors of metabolism or certification by the American Board of Medical Genetics in Clinical Genetics with extensive experience in the diagnosis and treatment of galactosemia and inborn errors of metabolism.  Consultants should have the capacity to provide a mulitidisciplinary approach to care, including the availability on-site of specially trained metabolic dieticians.

4)         Congenital Adrenal Hyperplasia:  training in Pediatric Endocrinology with membership in the Lawson Wilkins Pediatric Endocrinology Society or certification of special competence in Pediatric Endocrinology by the American Board of Pediatrics with at least one year experience post-training, in diagnosis and treatment of endocrine disorders.

5)         Biotinidase Deficiency:  certification by the American Board of Medical Genetics in Clinical Biochemical Genetics with at least one year of experience post-training in the diagnosis and treatment of children with biotinidase deficiency and inborn errors of metabolism or certification by the American Board of Medical Genetics in Clinical Genetics with extensive experience in the diagnosis and treatment of biotinidase deficiency and inborn errors of metabolism.  Consultants should have the capacity to provide a multidisciplinary approach to care, including the availability on-site of specially trained metabolic dieticians.

6)         Sickle Cell Disease:  training in Pediatric Hematology and certification of special competence in Pediatric Hematology-Oncology by the American Board of Pediatrics with at least one year experience post-training in diagnosis and treatment of hematological disorders.

7)         Fatty Acid Oxidation Disorders:  certification by the American Board of Medical Genetics in Clinical Biochemical Genetics with at least one year of experience post-training in the diagnosis and treatment of fatty acid oxidation disorders or certification by the American Board of Medical Genetics in Clinical Genetics with extensive experience in the diagnosis and treatment of fatty acid oxidation disorders.  Consultants should have the capacity to provide a multidisciplinary approach to care, including the availability on-site of specially trained metabolic dieticians.

8)         Cystic Fibrosis:  certification by the American Board of Pediatrics in Pediatric Pulmonology or Pediatric Gastroenterology with at least one year post-training experience in diagnosis and treatment of children with CF.  Consultants should provide prompt access to quantitative pilocarpine iontophoresis sweat chloride testing in a laboratory that meets all CLSI standards.  Consultants should provide a multidisciplinary approach to care, including the availability of on-site genetic counselors, dieticians, respiratory therapists and social workers.  Consultants should provide access to microbiology laboratories that use CF-specific protocols for detection of respiratory tract infection.

(Source:  Amended at 31 Ill. Reg. 13203, effective August 28, 2007)